Hypertension

• FDA approval · 2020-08-20
  FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)

  FDA approved a supplemental application for BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide) from Cosette Pharmaceuticals, Inc.

• FDA approval · 2020-08-20
  FDA Approved: FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)

  The FDA approved a supplemental application for Fosinopril sodium and hydrochlorothiazide from Aurobindo Pharma Limited. The approval covers…

• FDA approval · 2020-08-20
  FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for hydrochlorothiazide from Actavis Pharma, Inc., indicating a regulatory action on this drug (such…

• FDA approval · 2020-08-20
  FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  The FDA approved a supplemental application for Hydrochlorothiazide from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals Inc.), authori…

• FDA approval · 2020-08-20
  FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)

  The FDA approved a supplemental application for Diovan HCT (valsartan and hydrochlorothiazide) submitted by Novartis Pharmaceuticals Corpora…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2020-08-20
  FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (GSMS, Incorporated)

  FDA approved a supplemental application for a generic fixed-dose combination of lisinopril and hydrochlorothiazide for hypertension.

• FDA approval · 2020-08-20
  FDA Approved: CAPTOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

  The FDA approved a supplemental (ANDA) application for a generic captopril and hydrochlorothiazide combination tablet submitted by Rising Ph…

• FDA approval · 2020-08-20
  FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for hydrochlorothiazide from Teva Pharmaceuticals USA, Inc., granting an update to the generic produ…

• FDA approval · 2020-08-20
  FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)

  The FDA approved a supplemental application for HYDROCHLOROTHIAZIDE from Oxford Pharmaceuticals, LLC.

• FDA approval · 2020-08-13
  FDA Approved: IRBESARTAN — Supplemental Application (Solco Healthcare U.S., LLC)

  FDA approved Solco Healthcare U.S., LLC's supplemental application for IRBESARTAN, authorizing the generic product's marketing.

• FDA approval · 2020-08-07
  FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Exelan Pharmaceuticals, Inc.)

  The FDA granted a supplemental approval for the lisinopril and hydrochlorothiazide tablets from Exelan Pharmaceuticals.

• FDA approval · 2020-08-04
  FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)

  The FDA approved BluePoint Laboratories' supplemental application for clonidine hydrochloride (ANDA), granting a supplemental approval for t…

• FDA approval · 2020-07-30
  FDA Approved: CAPTOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

  FDA approved a supplemental application for CAPTOPRIL AND HYDROCHLOROTHIAZIDE (Rising Pharma Holdings, Inc.), a combination antihypertensive…

• FDA approval · 2020-07-29
  FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  FDA approved a supplemental application for hydrochlorothiazide from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

• FDA approval · 2020-07-24
  FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)

  The FDA approved a supplemental application for ramipril (generic ramipril) filed by Chartwell RX, LLC., under ANDA 078745.

• FDA approval · 2020-07-16
  FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (GSMS, Incorporated)

  The FDA approved a supplemental application for a lisinopril and hydrochlorothiazide fixed-dose combination from GSMS, Incorporated.

• FDA approval · 2020-07-16
  FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)

  The FDA approved a supplemental application for Lisinopril and Hydrochlorothiazide from Aurobindo Pharma Limited, a generic combination used…

• FDA approval · 2020-07-10
  FDA Approved: VALSARTAN — Supplemental Application (Solco Healthcare US, LLC)

  FDA approved a supplemental application for VALSARTAN by Solco Healthcare US, LLC.

• FDA approval · 2020-07-09
  FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Original Application (Edenbridge Pharmaceuticals LLC.)

  FDA approved a generic bisoprolol fumarate and hydrochlorothiazide tablet under an original ANDA from Edenbridge Pharmaceuticals LLC.

• FDA approval · 2020-07-07
  FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for the generic fixed-dose combination of lisinopril and hydrochlorothiazide from Actavis Pharma, In…

• FDA approval · 2020-07-06
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Eugia US LLC)

  FDA approves Verapamil hydrochloride as an original application generic; the product is used to treat hypertension, angina, and certain arrh…

• FDA approval · 2020-07-01
  FDA Approved: FUROSEMIDE — Original Application (Gland Pharma Limited)

  FDA approves the original generic application for furosemide from Gland Pharma Limited.

• FDA approval · 2020-06-17
  FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application from Prasco Laboratories for aliskiren hemifumarate (aliskiren), enabling the marketing of a generic…

• FDA approval · 2020-06-02
  FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare US, LLC)

  FDA approved a supplemental application for a generic fixed-dose combination of irbesartan and hydrochlorothiazide for hypertension, manufac…

• FDA approval · 2020-05-31
  FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)

  FDA approves a supplemental ANDA for furosemide from Solco Healthcare LLC.